Aquestive officer exercises warrant for 2,293 shares
Rhea-AI Filing Summary
Aquestive Therapeutics, Inc. (AQST) reported that Chief People Officer Peter E. Boyd exercised a Common Stock Purchase Warrant on September 9, 2026 to acquire 2,293 shares of common stock at an exercise price of $0.96 per share, a cash exercise of a warrant issued in June 2022. The corresponding warrant position of 2,293 warrant rights was fully exercised, leaving no remaining warrants from this grant, and Boyd now holds 284,024 shares of Aquestive common stock directly. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
2,293 shares exercised/converted
Exercise
2 txns
Insider
Boyd Peter E.
Role
Chief People Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Warrant (Right to Buy) | 2,293 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock F1 | 2,293 | $0.96 | $2K |
Holdings After Transaction:
Warrant (Right to Buy) — 0 contracts (Direct);
Common Stock — 284,024 shares (Direct)
Footnotes (1)
- F1. Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share.
Key Figures
Warrant shares exercised: 2,293 shares
Exercise price: $0.96 per share
Common shares acquired: 2,293 shares
+4 more
7 metrics
Warrant shares exercised
2,293 shares
Common Stock Purchase Warrant exercised on September 9, 2026
Exercise price
$0.96 per share
Exercise price of the Common Stock Purchase Warrant
Common shares acquired
2,293 shares
Shares of common stock received upon warrant exercise
Direct holdings after transaction
284,024 shares
Directly owned AQST common shares after September 9, 2026 transaction
Warrant issue date
June 8, 2022
Date the Common Stock Purchase Warrant was issued
Warrant exercisability date
December 8, 2022
Date from which the warrant became exercisable
Warrant expiration date
June 8, 2027
Expiration date of the Common Stock Purchase Warrant
Key Terms
Common Stock Purchase Warrant, Securities Purchase Agreement, exercise price
3 terms
Common Stock Purchase Warrant financial
"Represents the exercise for cash of a Common Stock Purchase Warrant issued"
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
Securities Purchase Agreement financial
"issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
exercise price financial
"expires on June 8, 2027, and has an exercise price of $0.96 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transaction did AQST report for Chief People Officer Peter E. Boyd?
AQST reported that Peter E. Boyd exercised a Common Stock Purchase Warrant on September 9, 2026, acquiring 2,293 shares of common stock at an exercise price of $0.96 per share through a cash exercise of the warrant.
What derivative security did the AQST insider exercise and what were its key terms?
The insider exercised a Common Stock Purchase Warrant covering 2,293 shares, issued June 8, 2022 under a Securities Purchase Agreement, which became exercisable December 8, 2022, expires June 8, 2027, and has an exercise price of $0.96 per share.
Was the AQST insider’s September 9, 2026 transaction under a Rule 10b5-1 plan?
No. The filing indicates that the Rule 10b5-1 checkbox is not marked, so no Rule 10b5-1 trading plan is reported for the September 9, 2026 warrant exercise and related acquisition of common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
